Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Inosine had a tendency to enhance the efficacy of immune-checkpoint inhibitors and reduced immunotherapy-related adverse reactions.
Authors
- Haiqing Zhao (ORCID: https://orcid.org/0009-0003-5233-3528)
- Dong Yin (ORCID: https://orcid.org/0000-0002-1878-4849)
- Hongchao Zhen
- Zhihao He (ORCID: https://orcid.org/0000-0003-2185-6089)
- Wei Zhang (ORCID: https://orcid.org/0009-0006-6821-1420)
- Qin Li (ORCID: https://orcid.org/0000-0002-2470-6089)
- Yuting Lu (ORCID: https://orcid.org/0000-0002-2770-7300)
Institutions
- Capital Medical University (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70143
- Citations
- 14
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.96
Funders
- National Natural Science Foundation of China